Combat Drugs reports standalone net profit of Rs 0.07 crore in the June 2018 quarter

Explore Business Standard
Associate Sponsors

Sales rise 12050.00% to Rs 4.86 crore
Net profit of Combat Drugs reported to Rs 0.07 crore in the quarter ended June 2018 as against net loss of Rs 0.08 crore during the previous quarter ended June 2017. Sales rose 12050.00% to Rs 4.86 crore in the quarter ended June 2018 as against Rs 0.04 crore during the previous quarter ended June 2017. ParticularsQuarter EndedJun. 2018Jun. 2017% Var.Sales4.860.04 12050 OPM %1.44-200.00 -PBDT0.07-0.08 LP PBT0.07-0.08 LP NP0.07-0.08 LPPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
First Published: Jul 23 2018 | 5:02 PM IST